Physician profile
Steven L Kidd
NPI 1700852589
$3,932.40
in general payments reported to CMS, 2019-2025
9 companies · $1,459 in 2025
The $1,459 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $216 · 2021: $34.73 · 2022: $44.34 · 2023: $823 · 2024: $1,355 · 2025: $1,459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,810 · Travel and Lodging: $828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,809.54 |
| Travel and Lodging | $827.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,207.32 | 2023-2025 | Pascal, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $1,119.93 | 2020-2025 | General - Vascular Access, General - Therapies |
| Angiodynamics, INC. | $206.59 | 2022-2024 | Alphavac |
| Abiomed | $156.05 | 2023 | Impella |
| Reflow Medical INC | $80.00 | 2023 | |
| Inari Medical, INC. | $61.09 | 2020 | |
| Cardiovascular Systems INC. | $44.16 | 2021-2023 | Diamondback Coronary |
| Ancora Heart, INC. | $35.23 | 2025 | Accucinch |
| Abbott Laboratories | $22.03 | 2023 | Perclose Prostyle |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kidd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.